Radiation InjuriesRadiation DosageAntineoplastic AgentsRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyRadiotherapy DosageRadiationNeoplasmsCell Line, TumorCombined Modality TherapyRadiation ProtectionRadiation OncologyDrug Screening Assays, AntitumorRadiotherapy, ConformalRadiation MonitoringRadiotherapy, Intensity-ModulatedDoxorubicinApoptosisDose FractionationRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation PneumonitisCisplatinCell SurvivalBrachytherapyImmune SystemRadiation-Sensitizing AgentsDrug Resistance, NeoplasmAntineoplastic Agents, PhytogenicMice, Inbred BALB CRadiometryNeoplasms, Radiation-InducedGamma RaysRadiation Injuries, ExperimentalAntibiotics, AntineoplasticTreatment OutcomeRadiosurgeryTumor Cells, CulturedDrug Delivery SystemsTime FactorsMice, Inbred C57BLCell ProliferationBrain NeoplasmsImmunity, InnateMice, NudeCosmic RadiationXenograft Model Antitumor AssaysBreast NeoplasmsDrug CarriersDNA DamageRadiotherapy, Computer-AssistedImmunity, CellularAntineoplastic Combined Chemotherapy ProtocolsCranial IrradiationHead and Neck NeoplasmsEtoposideParticle AcceleratorsNeoplasm Recurrence, LocalPaclitaxelRadiotherapy, Image-GuidedAntibody FormationRadiation-Protective AgentsBackground RadiationDose-Response Relationship, DrugEllipticinesFluorouracilSignal TransductionUltraviolet RaysProstatic NeoplasmsRadiodermatitisT-LymphocytesFlow CytometryLung NeoplasmsCytokinesCamptothecinAdenocarcinomaCarcinoma, Squamous CellRadiotherapy, High-EnergyNeoplasm StagingTumor BurdenImmune ToleranceOrgans at RiskSurvival AnalysisRadiation EffectsImmunityCell CycleInhibitory Concentration 50Lymphocyte ActivationDrug Resistance, MultipleCells, CulturedMolecular StructureP-GlycoproteinCobalt RadioisotopesImmunoglobulin GCell LineRetrospective StudiesDrug DesignDendritic Cells